97 related articles for article (PubMed ID: 2167918)
1. Tumoricidal effector mechanisms of murine BCG-activated macrophages: role of TNF in conjugation-dependent and conjugation-independent pathways.
Klostergaard J; Stoltje PA; Kull FC
J Leukoc Biol; 1990 Sep; 48(3):220-8. PubMed ID: 2167918
[TBL] [Abstract][Full Text] [Related]
2. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
Klostergaard J; Leroux ME; Hung MC
J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent.
Nascimento FR; Ribeiro-Dias F; Russo M
Braz J Med Biol Res; 1998 Dec; 31(12):1593-6. PubMed ID: 9951556
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol.
Burnette-Curley D; Cabral GA
Proc Soc Exp Biol Med; 1995 Oct; 210(1):64-76. PubMed ID: 7675800
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
6. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
Remels L; Fransen L; Huygen K; De Baetselier P
J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
[TBL] [Abstract][Full Text] [Related]
7. L-arginine independent macrophage tumor cytotoxicity.
Klostergaard J; Leroux ME
Biochem Biophys Res Commun; 1989 Dec; 165(3):1262-6. PubMed ID: 2692564
[TBL] [Abstract][Full Text] [Related]
8. Separation of soluble amoebicidal and tumoricidal activity of activated macrophages.
Fischer-Stenger K; Cabral GA; Marciano-Cabral F
J Protozool; 1992; 39(1):235-41. PubMed ID: 1560419
[TBL] [Abstract][Full Text] [Related]
9. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor necrosis factor in monocyte/macrophage tumor cytotoxicity in vitro.
Klostergaard J
Nat Immun Cell Growth Regul; 1987; 6(4):161-6. PubMed ID: 3317006
[TBL] [Abstract][Full Text] [Related]
11. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
12. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.
Decker T; Lohmann-Matthes ML; Gifford GE
J Immunol; 1987 Feb; 138(3):957-62. PubMed ID: 3492537
[TBL] [Abstract][Full Text] [Related]
13. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
14. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent.
Day DB; Zachariades NA; Gooding LR
Cell Immunol; 1994 Aug; 157(1):223-38. PubMed ID: 8039246
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor as a potent effector molecule for tumor cell killing by activated rat peritoneal macrophages in vitro.
Kusenda J; Kalafut F; Klobusická M; Novotná L
Neoplasma; 1992; 39(1):23-8. PubMed ID: 1528301
[TBL] [Abstract][Full Text] [Related]
16. Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages.
Higuchi M; Higashi N; Taki H; Osawa T
J Immunol; 1990 Feb; 144(4):1425-31. PubMed ID: 2303713
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.
Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X
Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
19. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.
Klostergaard J; Leroux ME; Ezell SM; Kull FC
Cancer Res; 1987 Apr; 47(8):2014-9. PubMed ID: 3828989
[TBL] [Abstract][Full Text] [Related]
20. Activated macrophages use different cytolytic mechanisms to lyse a virally infected or a tumor target.
LeBlanc PA; Heath LS; Um HD
J Leukoc Biol; 1990 Jul; 48(1):1-6. PubMed ID: 2162899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
